Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL

被引:0
|
作者
Isabelle Bartram
Ulrike Erben
Jutta Ortiz-Tanchez
Katja Blunert
Cornelia Schlee
Martin Neumann
Sandra Heesch
Claudia D. Baldus
机构
[1] Charité - Universitätsmedizin Berlin,Department of Hematology and Oncology, Campus Benjamin Franklin
[2] Charité - Universitätsmedizin Berlin,Department of Gastroenterology, Infectiology and Rheumatology, Campus Benjamin Franklin
来源
BMC Cancer | / 15卷
关键词
T-cell acute lymphoblastic leukemia; Chemotherapy resistance; Insulin-like growth factor-system; IGFBP7;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 35 条
  • [21] JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias
    C Delgado-Martin
    L K Meyer
    B J Huang
    K A Shimano
    M S Zinter
    J V Nguyen
    G A Smith
    J Taunton
    S S Winter
    J R Roderick
    M A Kelliher
    T M Horton
    B L Wood
    D T Teachey
    M L Hermiston
    Leukemia, 2017, 31 : 2568 - 2576
  • [22] MNK1 Inhibitor CGP57380 Overcomes the Activation of eIF4E Induced By mTORC1 Inhibitor: The Mechanism of Synergic Killing on T-ALL Cells
    Huang, XianBo
    He, Wei
    Jin, Jie
    Qian, Wenbin
    BLOOD, 2014, 124 (21)
  • [23] Knockdown of CCR7 or Its Ligands Causes a Loss of Central Nervous System Involvement in Notch1 Induced T-ALL
    Buonamici, Silvia
    Trimarchi, Thomas
    Klinakis, Apostolos
    Reavie, Linsey
    Mar, Brenton G.
    Gehrie, Eric
    Kuan, Emma L.
    Randolph, Gwendalyn J.
    Bromberg, Jonathan
    Aifantis, Iannis
    BLOOD, 2008, 112 (11) : 81 - 81
  • [24] Lipophagy As a Mechanism of Resistance in T-ALL Following Energetic Crisis Induced By Oxphos/MCT1 Blockade: Strategies to Eradicate Residual Disease
    Baran, Natalia
    Patel, Shraddha
    Ramage, Cassandra L.
    Lodi, Alessia
    Ortiz, Jose Enriquez
    Dhungana, Yogesh
    Collins, Meghan
    Skwarska, Anna
    Weng, Connie
    Hayes, Kala
    Zeng, Zhihong
    Cooper, Laurie
    Davis, Richard Eric
    Alatrash, Gheath
    Marszalek, Joseph R.
    Yu, Jiyang
    Bhattacharya, Pratip K.
    Tiziani, Stefano
    Konopleva, Marina
    BLOOD, 2022, 140 : 8831 - 8832
  • [25] Combination of Selective ALK Inhibitor ASP3026 with Inhibition of IGF-1R Signaling Overcomes Crizotinib Resistance in NCI-H2228 Human NSCLC Cells
    Ueno, Y.
    Mori, M.
    Shimada, I.
    Kondoh, Y.
    Konagai, S.
    Sakagami, H.
    Saito, R.
    Kamiyama, Y.
    Elizabeth, R.
    Kuromitsu, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 52 - 52
  • [26] MNK1 inhibitor CGP57380 overcomes mTOR inhibitor-induced activation of eIF4E: the mechanism of synergic killing of human T-ALL cells
    Xian-bo Huang
    Chun-mei Yang
    Qing-mei Han
    Xiu-jin Ye
    Wen Lei
    Wen-bin Qian
    Acta Pharmacologica Sinica, 2018, 39 : 1894 - 1901
  • [27] MNK1 inhibitor CGP57380 overcomes mTOR inhibitor-induced activation of eIF4E: the mechanism of synergic killing of human T-ALL cells
    Huang, Xian-bo
    Yang, Chun-mei
    Han, Qing-mei
    Ye, Xiu-jin
    Lei, Wen
    Qian, Wen-bin
    ACTA PHARMACOLOGICA SINICA, 2018, 39 (12) : 1894 - 1901
  • [28] MicroRNA let-7i induced autophagy to protect T cell from apoptosis by targeting IGF1R
    Hou, Chunfeng
    Zhu, Mengzhu
    Sun, Min
    Lin, Yanliang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 453 (04) : 728 - 734
  • [29] RESISTANCE TO APO-1(CD95) INDUCED APOPTOSIS IN T-ALL IS DETERMINED BY A BCL-2 INDEPENDENT ANTI-APOPTOTIC PROGRAM
    DEBATIN, KM
    KRAMMER, PH
    LEUKEMIA, 1995, 9 (05) : 815 - 820
  • [30] The Combination of Venetoclax and Tofacitinib Induced Hematological Responses in Patients with Relapse/Refractory T-ALL with BCL2 Expression and Surface IL7R Expression or IL7R-Pathway Mutations (On behalf of the GRAALL)
    Cabannes, Aurelie
    Schmidt, Aline
    Brissot, Eolia
    Balsat, Marie
    Maury, Sebastien
    Isnard, Francoise
    Chevallier, Patrice
    Cacheux, Victoria
    Cluzeau, Thomas
    Graux, Carlos
    Lhermitte, Ludovic
    Dombret, Herve
    Boissel, Nicolas
    Asnafi, Vahid
    Rousselot, Philippe
    BLOOD, 2019, 134